{
    "Trade/Device Name(s)": [
        "Cannabinoids Urine Test",
        "Wondfo Cannabinoids Urine Test"
    ],
    "Submitter Information": "Guangzhou Wondfo Biotech Co., Ltd.",
    "510(k) Number": "K110182",
    "Predicate Device Reference 510(k) Number(s)": [
        "K020771"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LDJ"
    ],
    "Summary Letter Date": "May 16, 2011",
    "Summary Letter Received Date": "May 19, 2011",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.3870"
    ],
    "Regulation Name(s)": [
        "Cannabinoid Test System"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Cannabinoids"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic assay",
        "Lateral flow system"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Wondfo Cannabinoids Urine Test, an immunochromatographic lateral flow assay for qualitative detection of cannabinoids in urine",
    "Indications for Use Summary": "Qualitative determination of 50ng/mL of cannabinoids in human urine for prescription and over the counter use",
    "fda_folder": "Toxicology"
}